Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 228 | $116,134,138 |
Sells | 4 | $198,660,583 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 24 May 2022 | Purchase | 1,521 | 5.93 | 9,020 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 41 | 213.7994 | 8,766 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 54 | 152.2129 | 8,219 | I |
28 Mar 2024 19:04 | IGMS | IGM Biosciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 27 Mar 2024 | Purchase | 761 | 9.2673 | 7,052 | I |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 17 Nov 2023 | Purchase | 39 | 171.79 | 6,700 | I |
27 May 2022 16:44 | KOD | Kodiak Sciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 26 May 2022 | Purchase | 984 | 6.755 | 6,647 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 29 | 223.9374 | 6,494 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 30 | 208.6913 | 6,261 | I |
06 Jun 2022 17:07 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 06 Jun 2022 | Purchase | 921 | 6.3537 | 5,852 | I |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 31 | 183.16 | 5,678 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 20 May 2022 | Purchase | 946 | 5.8421 | 5,527 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 17 Aug 2023 | Purchase | 7,676 | 0.6924 | 5,315 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 20 May 2022 | Purchase | 883 | 5.8409 | 5,158 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 23 May 2022 | Purchase | 827 | 5.9874 | 4,952 | I |
15 Dec 2023 17:32 | IGMS | IGM Biosciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 13 Dec 2023 | Purchase | 769 | 5.7588 | 4,429 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 17 Aug 2023 | Purchase | 5,041 | 0.6928 | 3,492 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 15 | 217.9 | 3,268 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 15 | 213.625 | 3,204 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 16 Aug 2023 | Purchase | 4,434 | 0.6828 | 3,028 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 15 Aug 2023 | Purchase | 4,342 | 0.665 | 2,887 | I |
27 May 2022 16:44 | KOD | Kodiak Sciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 27 May 2022 | Purchase | 358 | 6.635 | 2,375 | I |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 12 | 185.9442 | 2,231 | I |
06 Jun 2022 17:07 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 02 Jun 2022 | Purchase | 279 | 5.8202 | 1,624 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 7 | 209.765 | 1,468 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 7 | 205.32 | 1,437 | I |
15 Dec 2023 17:32 | IGMS | IGM Biosciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 15 Dec 2023 | Purchase | 185 | 6.355 | 1,176 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 24 May 2022 | Purchase | 179 | 5.93 | 1,061 | I |
27 May 2022 16:44 | KOD | Kodiak Sciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 26 May 2022 | Purchase | 116 | 6.755 | 784 | I |
27 May 2022 16:44 | KOD | Kodiak Sciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 27 May 2022 | Purchase | 42 | 6.635 | 279 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 16 Aug 2023 | Purchase | 366 | 0.6828 | 250 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 15 Aug 2023 | Purchase | 358 | 0.665 | 238 | I |
15 Dec 2023 17:32 | IGMS | IGM Biosciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 15 Dec 2023 | Purchase | 15 | 6.355 | 95 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)